<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="941">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 10, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01094145</url>
  </required_header>
  <id_info>
    <org_study_id>UK-09157</org_study_id>
    <nct_id>NCT01094145</nct_id>
  </id_info>
  <brief_title>Deep Brain Stimulation (DBS) of the Nucleus Basalis Meynert (NBM) to Treat Cognitive Deficits in Light to Moderate Alzheimer's Disease</brief_title>
  <acronym>MeynD-DBS</acronym>
  <official_title>Deep Brain Stimulation of the Nucleus Basalis Meynert to Treat Cognitive Deficits in Light to Moderate Alzheimer's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cologne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Cologne</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the study at hand, six patients with light to moderate Alzheimer's disease will be&#xD;
      enrolled and implanted with bilateral electrodes in the nucleus basalis Meynert.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the study at hand, six patients with light to moderate Alzheimer's disease will be&#xD;
      enrolled and implanted with bilateral electrodes in the nucleus basalis Meynert. The&#xD;
      stereotactic implantation of the electrodes will be guided by computerized tomography (CT)&#xD;
      and magnetic resonance tomography (MRT).&#xD;
&#xD;
      Basically, even though deep brain stimulation is an invasive method, there are only few side&#xD;
      effects. Surgical risks correspond with the risk of DBS in morbus Parkinson or other movement&#xD;
      disorders (0,4-6%).&#xD;
&#xD;
      After the baseline examination, the patients will be implanted with the electrodes;&#xD;
      accordingly all follow-ups are accomplished postoperative. From the second week after the&#xD;
      operation, the conventional stimulation takes place as a doubleblind, randomized change&#xD;
      between ON and OFF periods. Modifications of the stimulation parameter to obtain the best&#xD;
      possible result are possible.&#xD;
&#xD;
      Throughout the one-year observation-period, the patients will be followed closely to monitor&#xD;
      the effects of DBS on their cognitive abilities, psychopathological well being, the quality&#xD;
      of life, praxie and nutritional condition using standardized neurological and psychiatric&#xD;
      rating scales.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">January 2013</completion_date>
  <primary_completion_date type="Actual">January 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>cognitive improvement</measure>
    <time_frame>one- year</time_frame>
    <description>improving cognitive outcome parameters assessed by a series of standardized neuropsychological tests</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>determination of the optimal stimulation parameter</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">6</enrollment>
  <condition>Alzheimer Disease</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Stimulator setting is OFF</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Deep Brain Stimulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Stimulator setting is ON</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Deep brain stimulation</intervention_name>
    <description>DBS in the Nucleus basalis Meynert</description>
    <arm_group_label>Deep Brain Stimulation</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  German speaking male/female subjects&#xD;
&#xD;
          -  age:60-80&#xD;
&#xD;
          -  AD assessed by DSM-IV, ICD-10 and NINCDS-ADRDA-Scale&#xD;
&#xD;
          -  no Lewy-Body-dementia or other form of dementia&#xD;
&#xD;
          -  MMST &gt;18 and &lt;26&#xD;
&#xD;
          -  stable psychopharmacological medication&#xD;
&#xD;
          -  no psychotic symptoms, no suicidal tendency&#xD;
&#xD;
          -  education for at least 8 years&#xD;
&#xD;
          -  written informed consent of the patient&#xD;
&#xD;
          -  consent of at least two family members&#xD;
&#xD;
          -  no contraindication regarding PET-examination&#xD;
&#xD;
          -  no contraindication regarding anesthesia or stereotactic operation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  legal accommodation&#xD;
&#xD;
          -  clinical co-morbidity&#xD;
&#xD;
          -  contraindication of MRT examination&#xD;
&#xD;
          -  psychotic symptoms last six months&#xD;
&#xD;
          -  aggressive behavior or suicidal tendency&#xD;
&#xD;
          -  verbal IQ &lt;85&#xD;
&#xD;
          -  stereotactic operation in previous history&#xD;
&#xD;
          -  neoplastic neurological diseases&#xD;
&#xD;
          -  serious organic disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Volker Sturm, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Cologne</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jens Kuhn, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Cologne</affiliation>
  </overall_official>
  <overall_official>
    <last_name>H. J. Freund, Prof. Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stellvertretender Leiter der Klinischen Prüfung Institut für Neurowissenschaften und Medizin (INM-7) Forschungszentrum Jülich</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Uni-Klinik Köln AöR</name>
      <address>
        <city>Cologne</city>
        <state>North Rhine Westphalia</state>
        <zip>50924</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <study_first_submitted>March 25, 2010</study_first_submitted>
  <study_first_submitted_qc>March 25, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 26, 2010</study_first_posted>
  <last_update_submitted>June 6, 2013</last_update_submitted>
  <last_update_submitted_qc>June 6, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 7, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Cologne</investigator_affiliation>
    <investigator_full_name>Jens Kuhn</investigator_full_name>
    <investigator_title>Prof. Dr. Jens Kuhn</investigator_title>
  </responsible_party>
  <keyword>(light to moderate)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
    <mesh_term>Cognition Disorders</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

